{"id":"continuous-metformin","safety":{"commonSideEffects":[{"rate":"10-30","effect":"Gastrointestinal disturbance (nausea, diarrhea, abdominal discomfort)"},{"rate":"3-10","effect":"Metallic taste"},{"rate":"10-30","effect":"Vitamin B12 deficiency"},{"rate":"<0.1","effect":"Lactic acidosis (rare)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Metformin is a biguanide that primarily works by decreasing gluconeogenesis in the liver and enhancing peripheral glucose uptake and utilization. The continuous formulation aims to maintain steady-state drug levels to optimize glycemic control throughout the day. It does not stimulate insulin secretion, making it suitable for monotherapy or combination therapy in type 2 diabetes.","oneSentence":"Metformin reduces hepatic glucose production and improves insulin sensitivity by activating AMP-activated protein kinase (AMPK) and inhibiting mitochondrial complex I.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:07:33.100Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 2 diabetes mellitus"}]},"trialDetails":[{"nctId":"NCT00445627","phase":"","title":"Effect of Short-Term Beta-Cell Rest in Adolescents and Young Adults With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2007-06-18","conditions":"Obesity, Overweight, Diabetes Mellitus, Type 2","enrollment":82},{"nctId":"NCT02365597","phase":"PHASE2","title":"An Efficacy and Safety Study of Erdafitinib (JNJ-42756493) in Participants With Urothelial Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2015-04-22","conditions":"Urothelial Cancer","enrollment":239},{"nctId":"NCT07226453","phase":"PHASE2","title":"Target Validation and Efficacy of Metformin in Patients With Posterior Fossa Group A (PFA) Ependymoma","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2026-03-04","conditions":"Posterior Fossa Ependymal Tumor","enrollment":30},{"nctId":"NCT03006172","phase":"PHASE1","title":"To Evaluate the Safety, Tolerability, and Pharmacokinetics of Inavolisib Single Agent in Participants With Solid Tumors and in Combination With Endocrine and Targeted Therapies in Participants With Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Genentech, Inc.","startDate":"2016-12-13","conditions":"Breast Cancer, Solid Tumor","enrollment":200},{"nctId":"NCT07291297","phase":"PHASE2","title":"Metformin Hydrochloride in Combination With Standard of Care Systemic Therapy in Previously Untreated Advanced Unresectable or Metastatic Soft Tissue Sarcoma","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2026-03-04","conditions":"Sarcoma Metastatic, Sarcoma, Soft Tissue","enrollment":50},{"nctId":"NCT04416269","phase":"PHASE4","title":"Oral Anti Diabetic Agents in the Hospital","status":"ACTIVE_NOT_RECRUITING","sponsor":"Emory University","startDate":"2020-08-07","conditions":"Diabetes Mellitus","enrollment":255},{"nctId":"NCT04850846","phase":"PHASE2","title":"Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Dana-Farber Cancer Institute","startDate":"2021-04-27","conditions":"Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma","enrollment":60},{"nctId":"NCT03856632","phase":"PHASE4","title":"Liraglutide Effect in Atrial Fibrillation","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Miami","startDate":"2019-03-18","conditions":"Atrial Fibrillation","enrollment":60},{"nctId":"NCT06044025","phase":"PHASE1","title":"A Feasibility Study Evaluating a Role for Maintenance Therapy in Patients With Biochemically Progressive Castration Sensitive Prostate Cancer on Intermittent Androgen Deprivation Therapy","status":"RECRUITING","sponsor":"University of Arkansas","startDate":"2024-04-11","conditions":"Castration Sensitive Prostate Cancer","enrollment":34},{"nctId":"NCT06948825","phase":"PHASE2","title":"Effectiveness Study of a Lifestyle Intervention Versus Metformin in Mothers With Recent Gestational Diabetes","status":"RECRUITING","sponsor":"George Washington University","startDate":"2025-10-27","conditions":"Weight Loss, Gestational Diabetes Mellitus in Pregnancy, Postpartum Care","enrollment":60},{"nctId":"NCT03862950","phase":"PHASE2","title":"A Trial of Metformin in Individuals With Fragile X Syndrome (Met)","status":"COMPLETED","sponsor":"University of Alberta","startDate":"2019-05-24","conditions":"Fragile X Syndrome, Fragile X Mental Retardation Syndrome, Mental Retardation, X-Linked","enrollment":125},{"nctId":"NCT00971243","phase":"PHASE2","title":"Efficacy and Safety of MP-513 in Combination With Metformin in Patients With Type 2 Diabetes","status":"COMPLETED","sponsor":"Tanabe Pharma Corporation","startDate":"2009-08","conditions":"Type 2 Diabetes Mellitus","enrollment":448},{"nctId":"NCT06445946","phase":"PHASE4","title":"DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes","status":"RECRUITING","sponsor":"Ohio State University","startDate":"2024-08-01","conditions":"Gestational Diabetes Mellitus, Pregnancy, High Risk","enrollment":1572},{"nctId":"NCT05313529","phase":"NA","title":"LIGHT-MCI Trial: GLP-1 Agonist, SGLT2 Inhibitor, and DPP-4 Inhibitor for MCI Remission in Type 2 Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School","startDate":"2022-10-08","conditions":"Type 2 Diabetes Mellitus, Mild Cognitive Impairment","enrollment":396},{"nctId":"NCT05023967","phase":"PHASE2","title":"Metformin and Nightly Fasting in Women With Early Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2023-04-04","conditions":"Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Breast Ductal Carcinoma In Situ","enrollment":120},{"nctId":"NCT07303127","phase":"NA","title":"Combination of Bitter Melon Extract and Snakehead Fish Powder to Reduce Glycaemia in Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Universitas Muhammadiyah Surakarta","startDate":"2021-06-01","conditions":"Type 2 Diabetes Mellitus (T2DM)","enrollment":80},{"nctId":"NCT04691960","phase":"PHASE2","title":"A Pilot Study of Ketogenic Diet and Metformin in Glioblastoma: Feasibility and Metabolic Imaging","status":"ACTIVE_NOT_RECRUITING","sponsor":"Weill Medical College of Cornell University","startDate":"2016-08","conditions":"Glioblastoma","enrollment":18},{"nctId":"NCT04414540","phase":"PHASE2","title":"Combining Pembrolizumab and Metformin in Metastatic Head and Neck Cancer Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Trisha Wise-Draper","startDate":"2020-08-31","conditions":"Head and Neck Squamous Cell Carcinoma","enrollment":20},{"nctId":"NCT07057479","phase":"PHASE3","title":"Phase III Trial of SGLT2 Inhibitor and Thiazolidinedione Fixed-Dose Combination vs. Monotherapy in Type 2 Diabetes Patients on Metformin","status":"WITHDRAWN","sponsor":"Eurofarma Laboratorios S.A.","startDate":"2026-09","conditions":"Type 2 Diabetes Mellitus (T2DM)","enrollment":""},{"nctId":"NCT05183204","phase":"PHASE2","title":"Paxalisib With a High Fat, Low Carb Diet and Metformin for Glioblastoma","status":"SUSPENDED","sponsor":"Weill Medical College of Cornell University","startDate":"2022-02-14","conditions":"Glioblastoma","enrollment":33},{"nctId":"NCT04841668","phase":"","title":"Gut-Brain-axis: Targets for Improvement of Cognition in the Elderly","status":"RECRUITING","sponsor":"Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta","startDate":"2021-04-10","conditions":"Type 2 Diabetes Mellitus","enrollment":136},{"nctId":"NCT07129473","phase":"PHASE2","title":"Hyperemesis Gravidarum Risk Reduction With Metformin","status":"NOT_YET_RECRUITING","sponsor":"University of Southern California","startDate":"2026-01","conditions":"Hyperemesis Gravidarum","enrollment":224},{"nctId":"NCT07274644","phase":"PHASE4","title":"Effects of iGlarLixi Versus iGlar on Liver Fat Content in Patients With Type 2 Diabetes Mellitus Combined With Metabolic Dysfunction-associated Steatotic Liver Disease","status":"ENROLLING_BY_INVITATION","sponsor":"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School","startDate":"2025-03-29","conditions":"Metabolic Dysfunction-Associated Steatotic Liver Disease, Diabetes Mellitus Type 2","enrollment":36},{"nctId":"NCT06280274","phase":"PHASE4","title":"Metformin Use in Patients Undergoing Total Joint Replacement Surgery","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2024-06-27","conditions":"Hyperglycemia","enrollment":40},{"nctId":"NCT04220021","phase":"PHASE2","title":"Safety and Therapeutic Potential of the FDA-approved Drug Metformin for C9orf72 ALS/FTD","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Florida","startDate":"2020-01-10","conditions":"C9orf72 Amyotrophic Lateral Sclerosis (ALS), Frontotemporal Dementia","enrollment":41},{"nctId":"NCT07027969","phase":"PHASE4","title":"Metabolic Surgery for Atrial Fibrillation Elimination","status":"NOT_YET_RECRUITING","sponsor":"Ali Aminian","startDate":"2026-02-01","conditions":"Atrial Fibrillation, Obesity and Obesity-related Medical Conditions","enrollment":100},{"nctId":"NCT04945148","phase":"PHASE2","title":"Oxidative Phosphorylation Targeting In Malignant Glioma Using Metformin Plus Radiotherapy Temozolomide","status":"RECRUITING","sponsor":"Hopital Foch","startDate":"2024-05-10","conditions":"Glioblastoma, IDH-wildtype","enrollment":640},{"nctId":"NCT04029480","phase":"PHASE3","title":"Ertugliflozin Type 2 Diabetes Mellitus (T2DM) Pediatric Study (MK-8835/PF-04971729) (MK-8835-059)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2019-10-08","conditions":"Type 2 Diabetes Mellitus","enrollment":166},{"nctId":"NCT06490874","phase":"","title":"Continuous Glucose Monitoring (CGM) Substudy of the DECIDE RCT","status":"WITHDRAWN","sponsor":"Ohio State University","startDate":"2025-09","conditions":"Gestational Diabetes Mellitus, Pregnancy, High Risk","enrollment":""},{"nctId":"NCT04392284","phase":"NA","title":"Developing an Adaptive Lifestyle Intervention Program in Family Medicine Clinics","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2021-04-19","conditions":"Insulin Resistance, Obesity, Diabetes","enrollment":40},{"nctId":"NCT02755844","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Metronomic Cyclophosphamide, Metformin and Olaparib in Endometrial Cancer Patients","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2016-09-23","conditions":"Recurrent Endometrial Cancer","enrollment":35},{"nctId":"NCT05260021","phase":"PHASE3","title":"A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2022-04-13","conditions":"Type2 Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2","enrollment":99},{"nctId":"NCT01471808","phase":"PHASE4","title":"Effects of Different Early Intensive Therapies on Long-term β-cell Function","status":"COMPLETED","sponsor":"Sun Yat-sen University","startDate":"2011-10","conditions":"Diabetes Mellitus, Type 2","enrollment":264},{"nctId":"NCT06257966","phase":"PHASE3","title":"A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Dulaglutide in Combination Therapy Diabetes Mellitus Type 2 Patients With Metformin","status":"ACTIVE_NOT_RECRUITING","sponsor":"Beijing Dongfang Biotech Co., Ltd.","startDate":"2024-07-17","conditions":"Type2 Diabetes Mellitus","enrollment":600},{"nctId":"NCT07145827","phase":"NA","title":"Effect of Metformin on Endometrial Thickness in Postmenopausal Breast Cancer Patients Receiving Tamoxifen","status":"COMPLETED","sponsor":"Uruk University","startDate":"2024-01-02","conditions":"Breast Cancer, Endometrial Hyperplasia and Endometrial Cancers","enrollment":60},{"nctId":"NCT05819853","phase":"PHASE3","title":"Role of Semaglutide in Restoring Ovulation in Youth and Adults With Polycystic Ovary Syndrome","status":"RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2023-11-03","conditions":"PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries, Obese","enrollment":80},{"nctId":"NCT05932251","phase":"","title":"Towards Precision Medicine for Diabetes in Pregnancy","status":"SUSPENDED","sponsor":"Zuyderland Medisch Centrum","startDate":"2023-06-19","conditions":"Gestational Diabetes, Gestational Diabetes Mellitus","enrollment":103},{"nctId":"NCT07092618","phase":"PHASE2, PHASE3","title":"Effectiveness of Alternative Therapies in Maintaining Weight Loss Achieved by GLP-1 Medications Post-Cessation","status":"RECRUITING","sponsor":"AgelessRx","startDate":"2024-12-17","conditions":"Longevity, GLP-1, Geroscience","enrollment":150},{"nctId":"NCT04300790","phase":"PHASE2","title":"Study to Evaluate the Effect of Metformin in the Prevention of HG in HR[+]/HER2[-] PIK3CA-mut Advanced BC Patients","status":"COMPLETED","sponsor":"MedSIR","startDate":"2020-10-23","conditions":"Breast Cancer","enrollment":69},{"nctId":"NCT05929495","phase":"PHASE2","title":"Phase 2, Open-label, Single-arm Study on the Use of Metformin as Adjunctive Therapy in High-grade Glioma","status":"RECRUITING","sponsor":"University of Milano Bicocca","startDate":"2024-02-12","conditions":"Glioblastoma, IDH-wildtype, Metformin, Malignancies","enrollment":25},{"nctId":"NCT07073768","phase":"PHASE3","title":"Comparison Between Efficacy of Trelagliptin and Sitagliptin in Type II Diabetic Patients","status":"ENROLLING_BY_INVITATION","sponsor":"Khyber Medical College, Peshawar","startDate":"2025-07-01","conditions":"Diabetes Mellitus Type 2, Glycemic Control for Diabetes Mellitus","enrollment":126},{"nctId":"NCT07065591","phase":"EARLY_PHASE1","title":"Anti-Diabetic Drug, Exercise and Healthy Diet for Knee Osteoarthritis With Overweight/Obesity","status":"NOT_YET_RECRUITING","sponsor":"The University of Hong Kong","startDate":"2025-10-01","conditions":"Osteoarthritis (OA) of the Knee","enrollment":100},{"nctId":"NCT06682130","phase":"PHASE2","title":"Glofitamab Bridging ASCT for Patients With Relapsed or Refractory DLBCL","status":"RECRUITING","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2024-11-10","conditions":"Diffuse Large B-cell Lymphoma(DLBCL)","enrollment":40},{"nctId":"NCT06085703","phase":"NA","title":"Effects of Henagliflozin on the Brain Function in T2DM Patients With Mild Cognitive Impairment: a Randomized, Parallel Controlled Clinical Trial","status":"COMPLETED","sponsor":"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School","startDate":"2024-04-01","conditions":"Type 2 Diabetes Mellitus, Mild Cognitive Impairment","enrollment":24},{"nctId":"NCT04207944","phase":"PHASE2","title":"The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Duke University","startDate":"2020-07-10","conditions":"IPMN, IPMN, Pancreatic","enrollment":100},{"nctId":"NCT05065372","phase":"PHASE1","title":"MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes","status":"RECRUITING","sponsor":"Kalie Tommerdahl","startDate":"2022-07-01","conditions":"Type 1 Diabetes, Diabetic Kidney Disease, Cardiovascular Diseases","enrollment":60},{"nctId":"NCT07001878","phase":"PHASE4","title":"Cannabis Potency Effects on Brain White Matter in Early Phase Psychosis","status":"NOT_YET_RECRUITING","sponsor":"Nova Scotia Health Authority","startDate":"2025-07-01","conditions":"Psychosis, Cannabis Use","enrollment":24},{"nctId":"NCT04090580","phase":"PHASE3","title":"Impact on Glycemic Variability in Newly Onset T2DM Patients Initiating Dapagliflozin Plus Metformin Versus Metformin Alone","status":"COMPLETED","sponsor":"Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran","startDate":"2019-10-27","conditions":"Type 2 Diabetes","enrollment":88},{"nctId":"NCT06942390","phase":"PHASE2","title":"Topical Metformin Versus Topical Ketotifen in Melasma Treatment","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2025-06-01","conditions":"Melasma","enrollment":60},{"nctId":"NCT01905046","phase":"PHASE3","title":"Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2015-11-23","conditions":"Atypical Ductal Breast Hyperplasia, BRCA1 Mutation Carrier, BRCA2 Mutation Carrier","enrollment":86},{"nctId":"NCT06033131","phase":"PHASE3","title":"PI4 - A Trial Assessing Metformin to Prolong Gestation in Preterm Preeclampsia","status":"RECRUITING","sponsor":"Lina Bergman","startDate":"2024-01-19","conditions":"Preeclampsia","enrollment":294},{"nctId":"NCT06107153","phase":"PHASE3","title":"Effect of Short-term Basal Insulin Initiation in Newly Diagnosed Type 2 Diabetes on 1-year Glycemic Control","status":"COMPLETED","sponsor":"University of Basrah","startDate":"2023-11-01","conditions":"Type2diabetes","enrollment":243},{"nctId":"NCT06452511","phase":"EARLY_PHASE1","title":"Comparing the Effect of Metformin vs. Pep2dia as an Adjunct to Letrozole on Ovulation Induction and Pregnancy Outcomes in Overweight Women With PCOS","status":"COMPLETED","sponsor":"Muhamed Ahmed Abdelmoaty Muhamed Alhagrasy","startDate":"2024-08-01","conditions":"PCOS","enrollment":100},{"nctId":"NCT06000462","phase":"PHASE4","title":"The Effect of Dapagliflozin on Weight Loss in Obese Adults Without Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"Oman Ministry of Health","startDate":"2024-04-22","conditions":"Obesity, Dapagliflozin Adverse Reaction, Weight Loss","enrollment":150},{"nctId":"NCT04809311","phase":"","title":"Remote Study Collecting Blood Glucose Values and Activity Data in Patients With Type 2 Diabetes on Different Treatments","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2024-04-30","conditions":"Diabetes Mellitus, Type 2","enrollment":156},{"nctId":"NCT06884683","phase":"PHASE2","title":"Nivolumab Plus Metformin in Metastatic Renal Cell Carcinoma","status":"TERMINATED","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2020-09-17","conditions":"Metastatic Renal Cell Carcinoma","enrollment":12},{"nctId":"NCT06693934","phase":"NA","title":"Jockey Club Precision Prevention Programme on Young Onset Diabetes","status":"RECRUITING","sponsor":"Juliana CN Chan","startDate":"2024-11-23","conditions":"Diabetes, Pre Diabetes, Hypertension","enrollment":9000},{"nctId":"NCT05743907","phase":"PHASE4","title":"Clinical Trial to Evaluate the Efficacy and Safety of DA-2811 When Added to Ongoing Metformin Monotherapy in Patients with Type 2 Diabetes Who Have Inadequate Glycemic Control","status":"COMPLETED","sponsor":"Dong-A ST Co., Ltd.","startDate":"2023-04-25","conditions":"Diabetes Mellitus","enrollment":231},{"nctId":"NCT06863532","phase":"NA","title":"Efficacy and Safety Comparison of Cofrogliptin Add-on Versus Metformin Dose-escalation in Type 2 Diabetes Patients Inadequately Controlled With SGLT-2 Inhibitors Plus Low-Dose Metformin:A Multicenter, Open-Label Trial","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-03-30","conditions":"Type 2 Diabetes","enrollment":80},{"nctId":"NCT06296836","phase":"PHASE4","title":"Effect of Continuing Versus Holding Metformin During Hospitalizations.","status":"RECRUITING","sponsor":"University of Illinois at Chicago","startDate":"2025-01-21","conditions":"Diabetes Mellitus, Type 2","enrollment":300},{"nctId":"NCT06045351","phase":"PHASE1","title":"Efficacy of Injectable Vitamin D Supplementation in Females With Polycystic Ovary Syndrome","status":"RECRUITING","sponsor":"Aga Khan University","startDate":"2024-01-01","conditions":"Anovulatory Infertility","enrollment":142},{"nctId":"NCT04275713","phase":"PHASE2","title":"Altered Tumor Oxygenation by Metformin, a Potential Step in Overcoming Radiotherapy Resistance in LACC","status":"COMPLETED","sponsor":"Oslo University Hospital","startDate":"2020-05-22","conditions":"Cervical Cancer","enrollment":41},{"nctId":"NCT06781775","phase":"PHASE4","title":"GDM: Insulin with or Without Metformin?","status":"RECRUITING","sponsor":"University of Virginia","startDate":"2024-12-12","conditions":"Gestational Diabetes","enrollment":130},{"nctId":"NCT03479476","phase":"PHASE2, PHASE3","title":"A Trial of Metformin in Individuals With Fragile X Syndrome","status":"COMPLETED","sponsor":"University of California, Davis","startDate":"2018-04-30","conditions":"Fragile X Syndrome, Fragile X Mental Retardation Syndrome, Mental Retardation, X Linked","enrollment":120},{"nctId":"NCT06353061","phase":"PHASE2","title":"Chemoradiotherapy With or Without Metformin in Locally Advanced Cervical Cancer","status":"RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2024-04-15","conditions":"Cervical Cancer, Radiotherapy, Metformin","enrollment":51},{"nctId":"NCT06713967","phase":"NA","title":"Comparison of Pregnancy Outcomes in Women with Polycystic Ovarian Syndrome with and Without Glucophage","status":"NOT_YET_RECRUITING","sponsor":"University of Health Sciences Lahore","startDate":"2025-02-02","conditions":"Polycystic Ovarian Syndrome (PCOS), Pregnancy Outcomes","enrollment":70},{"nctId":"NCT06613854","phase":"PHASE4","title":"Effect of Early Combination Antihyperglycemic Treatment on Metabolic Control in Individuals With Type 2 Diabetes","status":"RECRUITING","sponsor":"University Medical Centre Ljubljana","startDate":"2024-10-01","conditions":"Type 2 Diabetes Mellitus (T2DM)","enrollment":90},{"nctId":"NCT04899349","phase":"PHASE2","title":"Study of Safety and Efficacy of Dapagliflozin + Metformin XR Versus Metformin XR in Participants With HR+, HER2-, Advanced Breast Cancer While on Treatment With Alpelisib and Fulvestrant","status":"TERMINATED","sponsor":"Novartis Pharmaceuticals","startDate":"2022-04-06","conditions":"Breast Cancer","enrollment":2},{"nctId":"NCT06247748","phase":"PHASE1","title":"Influence of JY09 on Pharmacokinetics of Metformin , Rosuvastatin , and Digoxin and the QT Interval Study in Overweight Chinese Subjects","status":"COMPLETED","sponsor":"Beijing Dongfang Biotech Co., Ltd.","startDate":"2023-10-19","conditions":"Diabetes Mellitus, Type 2, Overweight","enrollment":28},{"nctId":"NCT03713801","phase":"PHASE1","title":"Impact of Metformin on Immunity","status":"COMPLETED","sponsor":"The University of Texas Health Science Center at San Antonio","startDate":"2019-01-14","conditions":"Aging, Vaccine Response Impaired","enrollment":18},{"nctId":"NCT03194945","phase":"PHASE4","title":"Effects of Sequential Treatment Based on Lina/MET After Short-term Intensive Insulin in Newly Diagnosed Type 2 Diabetes","status":"COMPLETED","sponsor":"Sun Yat-sen University","startDate":"2017-11-01","conditions":"Type 2 Diabetes Mellitus","enrollment":412},{"nctId":"NCT02523898","phase":"PHASE2","title":"Metformine and CC Compared With Placebo and CC for Induction Ovulation in PCOS Patients With Insulin Resistant","status":"TERMINATED","sponsor":"Semnan University of Medical Sciences","startDate":"2015-11","conditions":"Polycystic Ovary Syndrome, Hyperandrogenism","enrollment":388},{"nctId":"NCT03503942","phase":"NA","title":"The Pre-Diabetes Interventions and Continued Tracking to Ease-out Diabetes (Pre-DICTED) Program","status":"COMPLETED","sponsor":"Singapore General Hospital","startDate":"2017-12-30","conditions":"Pre-diabetes","enrollment":751},{"nctId":"NCT06339086","phase":"PHASE3","title":"Efficacy and Safety of Semaglutide Injection in Subjects With Type 2 Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Chengdu Brilliant Pharmaceutical Co., Ltd.","startDate":"2024-04","conditions":"Type 2 Diabetes Mellitus","enrollment":478},{"nctId":"NCT05702905","phase":"PHASE4","title":"Semaglutide Improves Metabolic Abnormalities and Fertility in Obese Infertile Women With Polycystic Ovary Syndrome","status":"RECRUITING","sponsor":"Peking University First Hospital","startDate":"2023-05-09","conditions":"PCOS (Polycystic Ovary Syndrome), Semaglutide","enrollment":75},{"nctId":"NCT04343872","phase":"NA","title":"Preventing Diabetes in the Deep South: Extending Partnerships and Adapting Interventions to Reach Rural Communities at High Risk.","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2020-12-10","conditions":"Pre-diabetes","enrollment":36},{"nctId":"NCT03429543","phase":"PHASE3","title":"Diabetes Study of Linagliptin and Empagliflozin in Children and Adolescents (DINAMO)TM","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2018-03-20","conditions":"Diabetes Mellitus, Type 2","enrollment":175},{"nctId":"NCT06222476","phase":"NA","title":"Effect of Dorzagliatin on Renal Function Outcomes in People With Type 2 Diabetes: a Multicentric, Prospective, Randomized Study.","status":"NOT_YET_RECRUITING","sponsor":"Yan Bi","startDate":"2024-02-20","conditions":"Diabetic Nephropathy Type 2","enrollment":106},{"nctId":"NCT06217887","phase":"NA","title":"Efficacy Comparison of Polyethylene Glycol Loxenatide and Gliclazide on the Brain Function in T2DM Patients","status":"UNKNOWN","sponsor":"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School","startDate":"2020-05-10","conditions":"Type 2 Diabetes Mellitus, Cognitive Function Abnormal","enrollment":58},{"nctId":"NCT05816057","phase":"PHASE3","title":"A Study of the Efficacy and Safety of Semaglutide Injection in the Treatment of Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Hangzhou Jiuyuan Gene Engineering Co. Ltd.,","startDate":"2022-07-25","conditions":"Diabetes Mellitus, Type 2","enrollment":476},{"nctId":"NCT03309007","phase":"PHASE3","title":"A Double-Blind, Placebo-Controlled Trial of Anti-Aging, Pro-Autophagy Effects of Metformin in Adults With Prediabetes","status":"COMPLETED","sponsor":"University of New Mexico","startDate":"2017-09-01","conditions":"PreDiabetes, Aging","enrollment":25},{"nctId":"NCT04738799","phase":"NA","title":"The Impact of Food Order on Glycemic Excursions in Type 2 Diabetes Assessed by Continuous Glucose Monitoring","status":"COMPLETED","sponsor":"Weill Medical College of Cornell University","startDate":"2021-04-29","conditions":"Type 2 Diabetes","enrollment":20},{"nctId":"NCT02140788","phase":"PHASE4","title":"Effects of Metformin and Fish Oil on Treatment With Clozapine","status":"TERMINATED","sponsor":"Duke University","startDate":"2011-05","conditions":"Schizophrenia, Schizo-affective Disorder","enrollment":34},{"nctId":"NCT06057246","phase":"NA","title":"Individual Determinants of Postprandial Glucose Response in Type 2 Diabetes","status":"UNKNOWN","sponsor":"Federico II University","startDate":"2023-05-15","conditions":"Type 2 Diabetes","enrollment":144},{"nctId":"NCT03737240","phase":"PHASE3","title":"IDegLira HIGH Trial","status":"COMPLETED","sponsor":"Emory University","startDate":"2019-01-15","conditions":"Diabetes Mellitus","enrollment":145},{"nctId":"NCT02960659","phase":"PHASE1, PHASE2","title":"Title: Therapeutic Targets in African-American Youth With Type 2 Diabetes","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2017-05-09","conditions":"Type 2 Diabetes","enrollment":24},{"nctId":"NCT05177588","phase":"PHASE4","title":"Efficacy of Metformin as add-on Therapy in Non-Diabetic Heart Failure Patients","status":"COMPLETED","sponsor":"Cairo University","startDate":"2021-07-21","conditions":"Heart Failure","enrollment":70},{"nctId":"NCT05759312","phase":"PHASE1, PHASE2","title":"Zimberelimab Plus Metformin for Recurrent Ovarian Clear Cell Carcinoma","status":"UNKNOWN","sponsor":"Fudan University","startDate":"2023-03","conditions":"Ovarian Clear Cell Carcinoma","enrollment":20},{"nctId":"NCT03135301","phase":"PHASE3","title":"Letrozole in Clomiphene Resistant Infertile Women With Polycystic Ovarian Syndrome","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2017-06-20","conditions":"Infertility, Female","enrollment":80},{"nctId":"NCT01485614","phase":"PHASE3","title":"Study to Assess Safety & Efficacy of Sitagliptin as Initial Oral Therapy for Treatment of Type 2 Diabetes Mellitus in Pediatric Participants. (MK-0431-083)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2012-02-10","conditions":"Diabetes Mellitus, Type 2 Diabetes","enrollment":200},{"nctId":"NCT01131182","phase":"PHASE4","title":"Study of Sitagliptin Treatment in Patients With Type 2 Diabetes During Ramadan (0431-263)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2010-06-13","conditions":"Type 2 Diabetes Mellitus (T2DM)","enrollment":1147},{"nctId":"NCT04893148","phase":"PHASE4","title":"Efficacy and Safety of iGlarLixi Versus Insulin Glargine Plus Dulaglutide in Patients With Type 2 Diabetes","status":"UNKNOWN","sponsor":"Chungbuk National University Hospital","startDate":"2020-05-26","conditions":"Type 2 Diabetes Mellitus, Glucose, High Blood","enrollment":40},{"nctId":"NCT04994561","phase":"PHASE1","title":"VIAging Deceleration Trial Using Metformin, Dasatinib, Rapamycin and Nutritional Supplements","status":"WITHDRAWN","sponsor":"Vitality in Aging Research Group, Inc.","startDate":"2022-06","conditions":"Aging","enrollment":""},{"nctId":"NCT02836704","phase":"PHASE4","title":"Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)","status":"COMPLETED","sponsor":"Sanofi","startDate":"2016-09-09","conditions":"Diabetes Mellitus, Type 2","enrollment":892},{"nctId":"NCT02941367","phase":"PHASE4","title":"Safety Assessment of Lyxumia (Lixisenatide) and Sulfonylurea as Add-on Treatment to Basal Insulin in Uncontrolled Patients With Type 2 Diabetes Mellitus Who Elect to Fast During Ramadan","status":"COMPLETED","sponsor":"Sanofi","startDate":"2017-02-23","conditions":"Diabetes Mellitus, Type 2","enrollment":184},{"nctId":"NCT03958591","phase":"PHASE4","title":"Effects of Short-term Intensive De-escalation Therapy on Long-term Regimen Simplification","status":"UNKNOWN","sponsor":"Yanbing Li","startDate":"2019-05-01","conditions":"Diabetes type2","enrollment":274},{"nctId":"NCT04855513","phase":"NA","title":"Prevention of Pre-eclampsia Using Metformin: a Randomized Control Trial","status":"UNKNOWN","sponsor":"Hamad Medical Corporation","startDate":"2022-03-24","conditions":"Preeclampsia, Preeclampsia Severe, High Risk Pregnancy","enrollment":414},{"nctId":"NCT04468243","phase":"NA","title":"Pilot RCT Feasibility Study: Cancer and T2D","status":"TERMINATED","sponsor":"University of Florida","startDate":"2021-04-01","conditions":"Diabetes Mellitus, Type 2, Cancer","enrollment":3},{"nctId":"NCT04356742","phase":"PHASE3","title":"Efficacy and Safety of Dapagliflozin When Added to Ongoing Metformin and Evogliptin Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control","status":"COMPLETED","sponsor":"Dong-A ST Co., Ltd.","startDate":"2020-05-26","conditions":"Type 2 Diabetes","enrollment":198},{"nctId":"NCT01482286","phase":"PHASE3","title":"Effect of Weight and Insulin Sensitivity on Reproductive Function in PCOS","status":"TERMINATED","sponsor":"Pennington Biomedical Research Center","startDate":"2012-05","conditions":"Polycystic Ovary Syndrome","enrollment":32}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":10,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Metformin"],"phase":"phase_3","status":"active","brandName":"Continuous metformin","genericName":"Continuous metformin","companyName":"Mount Sinai Hospital, Canada","companyId":"mount-sinai-hospital-canada","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Metformin reduces hepatic glucose production and improves insulin sensitivity by activating AMP-activated protein kinase (AMPK) and inhibiting mitochondrial complex I. Used for Type 2 diabetes mellitus.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}